Details for New Drug Application (NDA): 076923
✉ Email this page to a colleague
NDA 076923 describes LIOTHYRONINE SODIUM, which is a drug marketed by Xgen Pharms, Biocon Pharma, Dr Reddys Labs Sa, Norvium Bioscience, Sigmapharm Labs Llc, Sun Pharm, Teva Pharms Usa, Watson Labs, and Zydus Lifesciences, and is included in ten NDAs. It is available from nineteen suppliers. Additional details are available on the LIOTHYRONINE SODIUM profile page.
The generic ingredient in LIOTHYRONINE SODIUM is liothyronine sodium. There are four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
The generic ingredient in LIOTHYRONINE SODIUM is liothyronine sodium. There are four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
Summary for 076923
| Tradename: | LIOTHYRONINE SODIUM |
| Applicant: | Xgen Pharms |
| Ingredient: | liothyronine sodium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 076923
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LIOTHYRONINE SODIUM | liothyronine sodium | INJECTABLE;INJECTION | 076923 | ANDA | XGen Pharmaceuticals DJB, Inc. | 39822-0151 | 39822-0151-1 | 1 VIAL in 1 CARTON (39822-0151-1) / 1 mL in 1 VIAL |
| LIOTHYRONINE SODIUM | liothyronine sodium | INJECTABLE;INJECTION | 076923 | ANDA | Afton Scientific, LLC | 59227-151 | 59227-151-01 | 1 VIAL in 1 CARTON (59227-151-01) / 1 VIAL, SINGLE-USE in 1 VIAL / 1 mL in 1 VIAL, SINGLE-USE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 0.01MG BASE/ML | ||||
| Approval Date: | Aug 17, 2005 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
